1,2,3,4-tetrahydroisoquinoline and Fatty Liver

1,2,3,4-tetrahydroisoquinoline has been researched along with Fatty Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, G; Huan, Y; Jia, C; Li, C; Li, R; Liu, Q; Liu, S; Liu, Z; Pan, X; Peng, J; Shen, Z; Sun, S; Wang, X; Zhou, T	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Fatty Liver

Article	Year
A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:11 Topics: 3T3-L1 Cells; Adipogenesis; Animals; Body Weight; Dyslipidemias; Fatty Liver; HEK293 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; PPAR gamma; Tetrahydroisoquinolines	2019

Article

Year

A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice.

Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:11

Topics: 3T3-L1 Cells; Adipogenesis; Animals; Body Weight; Dyslipidemias; Fatty Liver; HEK293 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; PPAR gamma; Tetrahydroisoquinolines

2019